Science & Enterprise subscription

Follow us on Twitter

  • A new enterprise in the U.K. is creating treatments with stem cells to repair damaged nerve cells in the inner ear… https://t.co/y4qOmPcuWK
    about 3 hours ago
  • New post on Science and Enterprise: Start-Up to Use Stem Cells for Hearing Loss https://t.co/dVEfRVHeTi #Science #Business
    about 3 hours ago
  • The U.S. Air Force is funding research at Massachusetts Institute of Technology to speed development of artificial… https://t.co/zbW38MuPMP
    about 6 hours ago
  • New post on Science and Enterprise: MIT, Air Force to Open A.I. Accelerator Lab https://t.co/tj0PbSXL9h #Science #Business
    about 6 hours ago
  • A solid majority of Americans express at least some doubts about biometrics for accessing computers, this weekend's… https://t.co/oUU1W1bX6E
    about 2 days ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Alliance Plans Adaptive Clinical Trials for Brain Cancer

(DARPA.gov)

12 November 2015. A global collaboration plans a series of clinical trials that address precise molecular targets testing treatments for glioblastoma multiforme, an aggressive brain cancer. The alliance combines medical teams, researchers, and patient advocates to employ adaptive clinical trials, a type of clinical study that enables investigators to adjust research tactics . . . → Read More: Alliance Plans Adaptive Clinical Trials for Brain Cancer

Patent Awarded for Early, Pre-Symptom Cancer Tests

Stefan Bossmann, left, and Deryl Troyer (Kansas State University)

16 June 2015. Three researchers at Kansas State University in Manhattan received a patent for an early-stage test that the inventors say can diagnose some solid tumor cancers well before symptoms develop. Kansas State chemistry professor Stefan Bossmann and anatomy-physiology professor Deryl Troyer, with . . . → Read More: Patent Awarded for Early, Pre-Symptom Cancer Tests

Trial Underway Testing Immunotherapy for Gout

Microscopic image of needle-like gout crystals (Bobjgalindo, Wikimedia Commons)

10 June 2015. An early-stage clinical trial is recruiting patients to test the safety of a treatment for severe gout that harnesses the immune system, but still avoids unwanted immune responses. The trial is conducted by the biotechnology company Selecta Biosciences at two sites . . . → Read More: Trial Underway Testing Immunotherapy for Gout

Early Trial Underway Testing Brain Cancer Drug

(Research.gov)

24 December 2014. Kinex Pharmaceuticals, a developer of cancer therapies, began an early-stage clinical trial of an experimental treatment for tumors of support cells in the brain. The Buffalo, New York biotechnology company says the first patient received the drug code-named KX2-361 in the trial taking place at Roswell Park Cancer Institute, . . . → Read More: Early Trial Underway Testing Brain Cancer Drug

University Starts Computer Science/Brain Research Consortium

3-D brain wiring illustration (NIH)

26 August 2014. Carnegie Mellon University in Pittsburgh organized an international consortium of researchers to apply computer science techniques to the study of brain research and behavior. The collaboration, known as BrainHub, includes researchers from nearby University of Pittsburgh, as well as Sun Yat-sen University in Guangzhou, China, . . . → Read More: University Starts Computer Science/Brain Research Consortium

Laser Activation Tested as Potential Cancer Drug Delivery

Paras Prasad (University at Buffalo)

16 May 2014. Researchers from University at Buffalo in New York developed and tested in the lab a process harnessing lasers to activate drugs inside the body to kill cancer cells. Findings from the proof-of-concept study, led by Buffalo’s Paras Prasad with colleagues from universities in China and . . . → Read More: Laser Activation Tested as Potential Cancer Drug Delivery

Early Trial Tests Stem Cell Immunotherapy for Liver Cancer

(NLM.NIH.gov)

An early stage clinical trial by California Stem Cell Inc. in Irvine tested a therapy harnessing the body’s immune system to treat a common form of liver cancer. The trial, conducted with eight patients in Shanghai, China, showed the treatments were safe for patients with hepatocellular carcinoma and did not cause complications, according . . . → Read More: Early Trial Tests Stem Cell Immunotherapy for Liver Cancer

Surgical Masks Shown to Cut Flu Transmission

Influenza ultrastructure illustration (Dan Higgins, CDC)

Public health researchers at University of Maryland, with colleagues at Harvard, Boston University, and University of Hong Kong identified the main ways flu virus spreads through populations and specifically recommend flu sufferers wear surgical masks to stop the virus. The team led by Maryland and Harvard professor . . . → Read More: Surgical Masks Shown to Cut Flu Transmission

Material Developed for Warm White Light from LED Bulbs

Zhengwei Pan, center, demonstrates a prototype of the new LED bulb, with colleagues Feng Liu, left, and Xufan Li (University of Georgia) Zhengwei Pan, center, demonstrates a prototype of the new LED bulb, with colleagues Feng Liu, left, and Xufan Li (University of Georgia)

Researchers from the U.S. and China created a light-emitting . . . → Read More: Material Developed for Warm White Light from LED Bulbs

Method Devised to Reliably Capture Circulating Cancer Cells

Sofia Merajver (University of Michigan)

Engineering and medical researchers at University of Michigan in Ann Arbor with colleagues in China developed a simple technique to capture circulating cancer cells believed to spread cancer from the original tumor to other parts of the body. The team from the labs of Michigan breast cancer researcher . . . → Read More: Method Devised to Reliably Capture Circulating Cancer Cells